Elagolix
Back to searchMolecule Structure
Scientific Name
Elagolix
Description of the Drug
Elagolix is a gonadotropin releasing hormone receptor antagonist used to treat moderate to severe pain in endometriosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11979
http://www.drugbank.ca/drugs/DB11979
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1642523 | ||
| Human Metabolome Database | HMDB0304892 | ||
| DrugBank | DB11979 | ||
| PubChem: Thomson Pharma | 16335306 | ||
| PubChem | 11250647 | ||
| Nikkaji | J2.888.161D | ||
| PDBe | F5O | ||
| EPA CompTox Dashboard | DTXSID40232348 | ||
| DrugCentral | 5293 | ||
| ChemicalBook | CB51518509 | ||
| Guide to Pharmacology | 8362 | ||
| rxnorm | ELAGOLIX | ELAGOLIX SODIUM | ORILISSA |
| ChEBI | 177453 | ||
| ZINC | ZINC000049888891 |
